06/06/2011
Arrien Pharmaceuticals Management participated in World Pharma Congress (WPC) Drug Discovery Summit meeting held on June 7-9, 2011 at Philadelphia on Targeting Alzheimer's and Parkinson's disease.

07/01/2011
Arrien Pharmaceuticals secures initial funding from company founders and initiated its New Drug Discovery (NDD), Medicinal Chemistry and Screening research activities on several of its pipeline programs.

07/01/2011
Arrien Pharmaceuticals, a small molecule Drug Discovery Company entered into an agreement with Oros Pharmaceuticals Pvt. Ltd (India) a Neurodegenerative/CNS Drug Discovery Company to combine the discovery efforts to advance the Oros Pipeline.

07/01/2011
Arrien Pharmaceuticals, a small molecule Drug Discovery Company based in USA entered into an agreement with Alveus Pharmaceuticals Pvt. Ltd (India) for all of its early Medicinal Chemistry/Discovery Research Services.

Alveus Pharmaceuticals, a Contract Research Organization (CRO) offers custom synthesis services for the Pharmaceutical/Biotechnology industries, research institutes and Universities for their drug discovery research and development process.